Résultats de la recherche - 228 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
2021.MethodsForty-six participating hospitals across 14 countries follow a similar generic protocol using the test-negative case-control design. We defined complete primary series vaccination (PSV) as two doses of ...
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.
Drug Resistance, Microbial Genomics Humans Salmonella Infections Salmonella typhimurium Abstract: Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality ...
Factors influencing SARS-CoV-2 infection rate in Belgian nursing homes’ residents during the first wave of COVID-19 pandemic
characteristics and infection rate among residents. Staff-resident interactions are key in SARS-CoV-2 transmission dynamics. Vaccination, regular staff testing, assessment of infection prevention and control ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
used a test-negative design and proportional hazard regression to estimate VE i and VE h, controlling for prior infection, time since vaccination, age, sex, residence and calendar week of ...
COVID-19 pandemic response in the Meuse-Rhine Euroregion: methods, participation and recommendations of a longitudinal cross-border study
time and the impact of infectious disease control in a cross-border setting, a prospective longitudinal study was conducted in the border area between Germany, Belgium and the Netherlands. In the spring ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
J Clin Pathol, Volume 76, Issue 3 (2023) Keywords: Early Detection of Cancer Female Human Papillomavirus Viruses Humans Papillomaviridae Papillomavirus Infections Sensitivity and Specificity Uterine ...
COVID-19 pandemic response in the Meuse-Rhine Euroregion: methods, participation and recommendations of a longitudinal cross-border study
examine the pandemic response over time and the impact of infectious disease control in a cross-border setting, a prospective longitudinal study was conducted in the border area between Germany, Belgium and ...
SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study
Health, Volume 23, Issue 1 (2023) Keywords: Belgium infection prevention and control SARS-CoV-2 School staff SCHOOL-AGED CHILDREN Seroprevalence Abstract: Background To protect school-aged children from the ...
Application of silver-based biocides in face masks intended for general use requires regulatory control
control SARS-CoV-2 infection needs to be balanced against possible toxicity due to inhalation exposure. Direct measurement of silver (particle) release to estimate exposure is problematic. Therefore, this ...